TRANSETHOSOMES: A NEW PROSPECT FOR ENHANCED TRANSDERMAL DELIVERY

被引:19
作者
Shaji, Jessy [1 ]
Bajaj, Rinki [1 ]
机构
[1] Principal KM Kundnani Coll Pharm, Dept Pharmaceut, 23,Jote Joy Bldg,Rambhau Salgaonkar Marg, Mumbai 400005, Maharashtra, India
关键词
Transethosomes; Transdermal; Lipophilic; Drug absorption;
D O I
10.13040/IJPSR.0975-8232.9(7).2681-85
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The skin covers a total surface area of approximately 1.8 m(2) and provides the contact between the human body and its external environment. Transdermal route of drug delivery has gained great interest in pharmaceutical research as it overcomes many problems associated with oral route of administration. Although the skin, particularly the stratum corneum presents a barrier to most drug absorption, it provides a large (1.2 m(2)) and accessible surface area for drug diffusion. Recently, various strategies have been used to augment the transdermal delivery of bioactives. Mainly, they include iontophoresis, electrophoresis, sonophoresis, chemical permeation enhancers, magnetophoresis, microneedles, vesicular systems (liposomes, niosomes, elastic liposomes such as ethosomes, transfersomes and transethosomes). Among these transethosomes appear to be more promising as they possess both lipophilic and hydrophilic regions and can accommodate drug molecules with wide range of solubility. Transethosomes can deform and pass through narrow constriction that is 5 to 10 times less than its own diameter. This high deformability gives better penetration of intact vesicles. These vesicles can be used for transdermal delivery of various classes of drugs like analgesics, anesthetics, corticosteroids, sex hormones, anticancer agents insulin etc.
引用
收藏
页码:2681 / 2685
页数:5
相关论文
共 25 条
[1]   Ethosomal nanocarriers: the impact of constituents and formulation techniques on ethosomal properties, in vivo studies, and clinical trials [J].
Abdulbaqi, Ibrahim M. ;
Darwis, Yusrida ;
Khan, Nurzalina Abdul Karim ;
Abou Assi, Reem ;
Khan, Arshad A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2016, 11 :2279-2304
[2]  
Akiladevi D., 2010, INT J CURR PHARM RES, V2, P2
[3]  
[Anonymous], 2011, PRONIOSOMES ETHOSOME, V2, P1988
[4]   Development, characterization, and skin delivery studies of related ultradeformable vesicles: transfersomes, ethosomes, and transethosomes [J].
Ascenso, Andreia ;
Raposo, Sara ;
Batista, Catia ;
Cardoso, Pedro ;
Mendes, Tiago ;
Praca, Fabiola Garcia ;
Lopes Badra Bentley, Maria Vitoria ;
Simoes, Sandra .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2015, 10 :5837-5851
[5]  
Bhana R, 2013, INT J PHARM PHARM SC, V5, P35
[6]   Lipid vesicles and other colloids as drug carriers on the skin [J].
Cevc, G .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (05) :675-711
[7]  
Dianzani C, 2014, DRUG DELIVERY NANOPA
[8]   Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates [J].
Filipe, Vasco ;
Hawe, Andrea ;
Jiskoot, Wim .
PHARMACEUTICAL RESEARCH, 2010, 27 (05) :796-810
[9]   Systematic Development of Transethosomal Gel System of Piroxicam: Formulation Optimization, In Vitro Evaluation, and Ex Vivo Assessment [J].
Garg, Varun ;
Singh, Harmanpreet ;
Bhatia, Amit ;
Raza, Kaisar ;
Singh, Sachin Kumar ;
Singh, Bhupinder ;
Beg, Sarwar .
AAPS PHARMSCITECH, 2017, 18 (01) :58-71
[10]   Ethosomes-based topical delivery system of antihistaminic drug for treatment of skin allergies [J].
Goindi, Shishu ;
Dhatt, Bhavnita ;
Kaur, Amanpreet .
JOURNAL OF MICROENCAPSULATION, 2014, 31 (07) :716-724